Evidence map›Paper›PMID 41788204›Full record

ArticleMiddle East journal of digestive diseases2025

Evaluating the Correlation Between Fecal Microbiota Profiles and Clinical Presentation in Pediatric Patients with Celiac Disease.

Nastaran Asri, Mohadeseh Mahmoudi Ghehsareh, Fahimeh Sadat Gholam-Mostafaei, Mehdi Azizmohammad Looha, Hamidreza Houri, Somayeh Jahani-Sherafat, Mohammad Rahmanian, Mostafa Rezaei Tavirani, Mohammad Rostami-Nejad

Abstract read
In one paragraph

Article in Middle East journal of digestive diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nastaran AsriStudent Research Committee, Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-1986-615X
Mohadeseh Mahmoudi GhehsarehCeliac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fahimeh Sadat Gholam-MostafaeiCeliac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mehdi Azizmohammad LoohaBasic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamidreza HouriFoodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Somayeh Jahani-SherafatLaser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad RahmanianCeliac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mostafa Rezaei TaviraniProteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad Rostami-NejadCeliac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-2495-1831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Celiac disease (CD) is an immune-mediated disorder triggered by gluten in genetically susceptible individuals, often presenting with diverse gastrointestinal and non-gastrointestinal symptoms. Emerging evidence suggests that alterations in gut microbiota composition may influence disease manifestation and clinical outcomes. We investigated the correlation between gut microbiota profiles and clinical features in pediatric patients with CD. Methods: 38 pediatric patients (mean age 10.24 years) with confirmed CD were enrolled from August 2021 to September 2022. We had the data on the relative abundance of various fecal microbiota from our previous study, and collected their clinical and demographic data through questionnaires. Genotyping of human leukocyte antigens (HLA)-DQ2 and HLA-DQ8 alleles was performed. Results: Significant correlations were found between gut microbiota and both gastrointestinal (GI) and non-GI symptoms. Enterobacteriaceae and Conclusion: Overall, the analysis revealed distinct microbiota patterns influenced by symptom presentation and HLA-DQ genotypes, underscoring the need for further research into the therapeutic potential of modifying gut microbiota in managing CD.

Indexed as

Celiac diseaseGastrointestinal symptomsGut microbiotaHLA-DQ genotypePediatric patients

Identifiers

PMID41788204
PMCPMC12958314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.